banner2

Getting started
L-Serine Benzyl Ester Hydrochloride

L-Serine Benzyl Ester Hydrochloride - Factory, Suppliers, Manufacturers from China

L-Serine Benzyl Ester Hydrochloride, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

L-Serine Benzyl Ester Hydrochloride CAS 60022-62-0 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — L-Serine Benzyl Ester Hydrochloride CAS 60022-62-0 Assay ≥98.0% (HPLC)
Read More

D-Proline Benzyl Ester Hydrochloride CAS 53843-90-6 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — D-Proline Benzyl Ester Hydrochloride CAS 53843-90-6 Assay ≥98.0% (HPLC)

Benzyl Glycinate Hydrochloride CAS 2462-31-9 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Glycine Benzyl Ester Hydrochloride CAS 2462-31-9 H-Gly-OBzl·HCl Purity >98.0% (HPLC)

H-Thr-OBzl·HCl CAS 33645-24-8 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — L-Threonine Benzyl Ester Hydrochloride CAS 33645-24-8 H-Thr-OBzl·HCl Purity >98.0% (HPLC)

H-Phe-OBzl·HCl CAS 2462-32-0 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — H-Phe-OBzl·HCl CAS 2462-32-0 L-Phenylalanine Benzyl Ester Hydrochloride Purity >99.0% (HPLC)

H-Pro-OBzl·HCl CAS 16652-71-4 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — H-Pro-OBzl·HCl CAS 16652-71-4 L-Proline Benzyl Ester Hydrochloride Purity >99.0% (HPLC)

H-D-Ser-OBzl.HCl CAS 151651-44-4 PURITY 98 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — D-Serine Benzyl Ester Hydrochloride CAS 151651-44-4 (H-D-Ser-OBzl.HCl) Assay 98.0~102.0%

banner1

Top Selling Products

Related Blog
Reviews

Sodium Salicylate CAS 54-21-7 USP35 Standard

Sodium Salicylate C7H5NaO3 160.10 Benzoic acid, 2-hydroxy-, monosodium salt; Monosodium salicylate [54-21-7]; UNII: WIQ1H85SYP. DEFINITION Sodium Salicylate contains NLT 98.0% and NMT 102.0% of so...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...
The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The Third Conference on Boron Chemistry of Chinese Chemical Society (CCS-CBS) will be held in Suzhou, Jiangsu Province from October 15 to 18, 2021. This conference will be hosted by Inorganic Chemi...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...

2022.12.20 05:14:35
2022.10.28 23:50:14
2022.08.14 14:53:38
2022.06.17 23:12:39
2022.06.07 11:07:49
2021.10.30 23:42:58

related search